Correspondence on "The increasing incidence of stage IV cervical cancer in the USA: what factors are related?" by Francoeur et al

Geetanjali D Datta^{1

2}, Marie-Helene Mayrand^{3

4}, Beth A Glenn^{5

6}

Affiliations

¹ Cancer Research Center for Health Equity, Cedars-Sinai Medical Center, Los Angeles, California, USA geetanjali.datta@cshs.org.
² Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
³ Research Center of the Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
⁴ Department of Obstetrics and Gynecology, Université de Montréal, Montreal, Quebec, Canada.
⁵ Department of Health Policy and Management, UCLA Jonathan and Karin Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, USA.
⁶ UCLA Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA.

Free article

Comment

Geetanjali D Datta et al. Int J Gynecol Cancer. 2023.

Free article

. 2023 Jan 3;33(1):136.

doi: 10.1136/ijgc-2022-004066.

Geetanjali D Datta^{1

2}, Marie-Helene Mayrand^{3

4}, Beth A Glenn^{5

6}

¹ Cancer Research Center for Health Equity, Cedars-Sinai Medical Center, Los Angeles, California, USA geetanjali.datta@cshs.org.
² Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
³ Research Center of the Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
⁴ Department of Obstetrics and Gynecology, Université de Montréal, Montreal, Quebec, Canada.
⁵ Department of Health Policy and Management, UCLA Jonathan and Karin Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, USA.
⁶ UCLA Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA.

No abstract available

Keywords: Cervical Cancer.

Conflict of interest statement

Competing interests: None declared.

The increasing incidence of stage IV cervical cancer in the USA: what factors are related?
Francoeur AA, Liao CI, Caesar MA, Chan A, Kapp DS, Cohen JG, Salani R, Chan JK. Francoeur AA, et al. Int J Gynecol Cancer. 2022 Sep 6;32(9):1115-1122. doi: 10.1136/ijgc-2022-003728. Int J Gynecol Cancer. 2022. PMID: 35981903